• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Transition metal oxoanionic compounds Transition metal sulfates

Research Brief on Titanium(IV) Oxysulfate (CAS: 13825-74-6) in Chemical and Biomedical Applications

Titanium(IV) oxysulfate (CAS: 13825-74-6) has recently gained significant attention in chemical and biomedical research due to its unique physicochemical properties and versatile applications. This compound, characterized by its sulfate-oxo-titanium structure, exhibits remarkable catalytic, photocatalytic, and biocompatible properties, making it a promising candidate for various industrial and medical applications. Recent studies have explored its potential in areas ranging from advanced material synthesis to drug delivery systems.

A 2023 study published in Advanced Materials demonstrated the exceptional photocatalytic efficiency of titanium(IV) oxysulfate in wastewater treatment applications. The research team developed a novel nanocomposite using 13825-74-6 as the primary photocatalyst, achieving 92% degradation efficiency of organic pollutants under visible light irradiation. This represents a significant improvement over traditional titanium dioxide-based photocatalysts, with the sulfate groups playing a crucial role in enhancing charge separation and light absorption properties.

In the biomedical field, researchers have investigated titanium(IV) oxysulfate for its potential in bone tissue engineering. A recent Biomaterials Science publication (2024) reported that scaffolds incorporating 13825-74-6 showed improved osteoconductivity and mechanical strength compared to conventional materials. The sulfate groups in the compound were found to mimic natural bone matrix components, promoting better cell adhesion and proliferation. This discovery opens new possibilities for developing advanced bone graft substitutes.

The compound's catalytic properties have also been explored in pharmaceutical synthesis. A 2023 Journal of Medicinal Chemistry study utilized titanium(IV) oxysulfate as a Lewis acid catalyst in the synthesis of complex heterocyclic compounds, achieving higher yields and enantioselectivity than traditional catalysts. The researchers attributed this performance to the unique electronic structure of 13825-74-6, which facilitates selective molecular interactions during key reaction steps.

Recent advances in nanomaterial synthesis have further expanded the applications of titanium(IV) oxysulfate. A team at MIT (2024) developed a novel method for creating ultra-thin titanium-based nanosheets using 13825-74-6 as a precursor. These nanosheets demonstrated exceptional electrical conductivity and surface area, making them ideal candidates for next-generation biosensors and energy storage devices. The research highlighted the compound's advantage in producing materials with precisely controlled morphology and composition.

Despite these promising developments, challenges remain in the large-scale production and application of titanium(IV) oxysulfate. Current research is focusing on optimizing synthesis methods to improve yield and purity while reducing production costs. Additionally, comprehensive toxicological studies are underway to fully evaluate the compound's safety profile for medical applications. The coming years are expected to see significant progress in both fundamental understanding and practical applications of this versatile material.

• 10034-96-5(Manganese sulfate monohydrate)
• 10101-68-5(Manganese(II) sulfate tetrahydrate)
• 19414-43-8(Sulfuric acid,titanium(3+) salt (2:1), hydrate (2:5) (8CI))
• 13444-72-9(Sulfuric acid,manganese(3+) salt (3:2))
• 7785-87-7(Manganese sulphate)
• 10343-61-0(dititanium tris(sulphate))
• 13693-11-3(Sulfuric acid, titanium(4+) salt (2:1))
• 19495-80-8(Sulfuric acid,titanium(3+) salt (2:1), tetrahydrate (8CI,9CI))
• 18130-44-4(Sulfuric acid, titaniumsalt (8CI,9CI))
• 15244-36-7(Manganese(II) Sulfate Pentahydrate)